Kodiak Sciences Inc (NASDAQ: KOD)
$3.04
-0.2000 ( -6.17% ) 222.1K
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.
Market Data
Open
$3.04
Previous close
$3.24
Volume
222.1K
Market cap
$159.18M
Day range
$2.91 - $3.25
52 week range
$1.37 - $7.77
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 12 | May 15, 2024 |
| ars | Annual reports | 1 | Apr 23, 2024 |
| def | Proxies and info statements | 28 | Apr 23, 2024 |
| 10-k | Annual reports | 81 | Mar 28, 2024 |
| 8-k | 8K-related | 12 | Mar 28, 2024 |
| 8-k | 8K-related | 13 | Nov 14, 2023 |
| 10-q | Quarterly Reports | 48 | Nov 14, 2023 |
| 8-k | 8K-related | 12 | Nov 06, 2023 |
| 8-k | 8K-related | 12 | Aug 17, 2023 |
| 10-q | Quarterly Reports | 49 | Aug 14, 2023 |